Solasia Pharma K.K.
Records under this name other than the patents Solasia Pharma K.K. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 5 of 5 · Back to Solasia Pharma K.K.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,968,738 | Compounds and methods for the treatment of cancer Term ended Term ended Jul 28, 2026 · From the USPTO record | Term ended | Term ended Jul 28, 2026 | From the USPTO record |
| US 8,334,398 | Compounds and methods for the treatment of cancer Term ended Term ended Jul 28, 2026 · From the USPTO record | Term ended | Term ended Jul 28, 2026 | From the USPTO record |
| US 8,865,764 | Compounds and methods for the treatment of cancer Term ended Term ended Jul 28, 2026 · From the USPTO record | Term ended | Term ended Jul 28, 2026 | From the USPTO record |
| US 8,796,329 | Method for controlling angiogenesis in animals Lapsed on the fee record Ended Aug 5, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 5, 2022 | From the USPTO record |
| US 8,252,773 | Combination therapy with organic arsenicals Lapsed on the fee record Ended Aug 28, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 28, 2016 | From the USPTO record |